Citigroup’s Cano Health, Inc. CANO Stock Holding History

Citigroup’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25	Closed	-$2.27K	–	5808
2023 Q1	$2.27K	Sell	25 -6,520	-100%	-$885K	﹤0.01%	5082
2022 Q4	$897K	Sell	6,545 -30,538	-82%	-$10.3M	﹤0.01%	2701
2022 Q3	$32.2M	Buy	+37,083	New	+$23.2M	0.02%	552
2022 Q2	–	Sell	-750	Closed	-$476K	–	6812
2022 Q1	$476K	Buy	+750	New	+$473K	﹤0.01%	3553
2021 Q4	–	Sell	-2,225	Closed	-$2.82M	–	6154
2021 Q3	$2.82M	Buy	+2,225	New	+$2.7M	﹤0.01%	2254

Other funds holding CANO

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GFPC

Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Citigroup's CANO Position: Q1 2024 in Review

Citigroup sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 348 shares — an estimated $2.04K sold.

Citigroup first reported a position in CANO in Q4 2020 and held it in 12 quarters. The position peaked at $17.4M in Q3 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

Citigroup reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
Citigroup sold 348 Cano Health, Inc. shares in Q1 2024, an estimated $2.04K.
Citigroup first reported a position in Cano Health, Inc. in Q4 2020 and held it in 12 quarters.
Citigroup's Cano Health, Inc. position peaked at $17.4M in Q3 2021.
6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.